GNI Group Ltd. (TYO:2160)
Japan · Delayed Price · Currency is JPY 2,482.00
-85.00 (-3.31%)
At close: Feb 6, 2026
GNI Group Market Cap
GNI Group has a market cap or net worth of 138.17 billion as of February 6, 2026. Its market cap has decreased by -11.83% in one year.
Market Cap
138.17B
Enterprise Value
122.85B
Revenue
25.78B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,482.00
Market Cap Chart
Since August 31, 2007, GNI Group's market cap has increased from 5.24B to 138.17B, an increase of 2,538.95%. That is a compound annual growth rate of 19.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 138.17B | 2.92% |
| Dec 30, 2025 | 134.25B | -21.38% |
| Dec 30, 2024 | 170.75B | 21.35% |
| Dec 29, 2023 | 140.72B | 112.73% |
| Dec 30, 2022 | 66.15B | -5.89% |
| Dec 30, 2021 | 70.29B | -10.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 201.57B |
| SanBio Company | 145.53B |
| Takara Bio | 97.42B |
| Nxera Pharma | 75.02B |
| Cuorips | 68.55B |
| Oncolys BioPharma | 50.53B |
| Healios K.K. | 43.17B |
| RaQualia Pharma | 26.40B |